# Kenya Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Kenya HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Kenya (KEN)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $3.8M
- Products: 25
- Buyer markets: 27
- Average CAGR: +21.5%
- Global sector size: $635.8B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $286.4B | $459.0K | $102.3B | -3.9% | 18 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $132.9B | $635.1 | $51.9B | +100.0% | 9 | +0.0% |
| HS 300214 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, mixed, put up in measured doses or in forms or packings for retail sale | $22.4B | $17.7K | $25.9B | +55.9% | 2 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $22.9B | $57.0K | $19.2B | +39.4% | 5 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $26.9B | $619.1K | $16.8B | -7.6% | 9 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $29.6B | $196.4K | $16.5B | +98.5% | 8 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $17.7B | $165.1K | $10.7B | -8.3% | 5 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $7.9B | $29.8K | $10.7B | -6.8% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $20.4B | $51.0K | $8.8B | +6.4% | 5 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $12.8B | $10.1K | $8.3B | -8.3% | 3 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $18.1B | $16.0K | $8.1B | -1.8% | 5 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $8.5B | $116.4K | $5.0B | +22.6% | 3 | +0.0% |
| HS 282200 - Cobalt oxides and hydroxides: commercial cobalt oxides | $1.6B | $0.0 | $3.1B | +6.7% | 1 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $4.8B | $550.9 | $2.8B | +100.1% | 1 | +0.0% |
| HS 370790 - Photographic goods: chemical preparations other than sensitised emulsions, put up in measured portions or put up for retail sale in a form ready for use | $3.2B | $1.1K | $2.8B | +9.1% | 2 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $3.8B | $1.9M | $2.2B | +26.7% | 2 | +0.1% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $125.8K | $2.0B | +24.0% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $3.6B | $18.2K | $1.8B | +9.4% | 2 | +0.0% |
| HS 321590 - Ink: writing, drawing and other inks, n.e.c. in heading no. 3215, whether or not concentrated or solid | $674.3M | $10.8K | $1.1B | +24.6% | 1 | +0.0% |
| HS 320611 - Colouring matter: pigments and preparations based on titanium dioxide, containing 80% or more by weight of titanium dioxide calculated on the dry matter | $1.1B | $212.7 | $997.2M | -28.0% | 1 | +0.0% |
| HS 294190 - Antibiotics: n.e.c. in heading no. 2941 | $883.6M | $9.7 | $990.0M | -53.8% | 1 | +0.0% |
| HS 300449 - Medicaments: containing alkaloids or their derivatives: other than ephedrine, pseudoephedrine (INN) or norephedrine or their salts: for therapeutic or prophylactic uses, packaged for retail sale | $1.5B | $2.2 | $841.5M | -23.1% | 1 | +0.0% |
| HS 381800 - Chemical elements: doped for use in electronics, in the form of discs, wafers or similar forms: chemical compounds doped for use in electronics | $2.2B | $985.7 | $833.8M | -12.8% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $31.8 | $803.3M | -14.9% | 1 | +0.0% |
| HS 293399 - Heterocyclic compounds: n.e.c. in headings no. 2933 | $734.9M | $164.1 | $798.7M | -23.3% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $108.6B calculated opportunity across 16 products.
- Switzerland, Liechtenstein (CHE): $36.6B calculated opportunity across 4 products.
- Germany (DEU): $25.0B calculated opportunity across 9 products.
- Belgium (BEL): $21.4B calculated opportunity across 5 products.
- China (CHN): $20.9B calculated opportunity across 7 products.
- Netherlands (NLD): $13.3B calculated opportunity across 3 products.
- United Kingdom (GBR): $13.1B calculated opportunity across 7 products.
- Spain (ESP): $9.9B calculated opportunity across 5 products.
- Canada (CAN): $8.4B calculated opportunity across 5 products.
- France (FRA): $7.0B calculated opportunity across 5 products.
- Italy (ITA): $5.7B calculated opportunity across 2 products.
- India (IND): $4.8B calculated opportunity across 5 products.

## Growth stars

- HS 382600: +100.1% average CAGR, $2.8B calculated opportunity.
- HS 300215: +100.0% average CAGR, $51.9B calculated opportunity.
- HS 300212: +98.5% average CAGR, $16.5B calculated opportunity.
- HS 300214: +55.9% average CAGR, $25.9B calculated opportunity.
- HS 300220: +39.4% average CAGR, $19.2B calculated opportunity.
- HS 300390: +26.7% average CAGR, $2.2B calculated opportunity.
- HS 321590: +24.6% average CAGR, $1.1B calculated opportunity.
- HS 300420: +24.0% average CAGR, $2.0B calculated opportunity.
- HS 330300: +22.6% average CAGR, $5.0B calculated opportunity.
- HS 300290: +9.4% average CAGR, $1.8B calculated opportunity.

## Diversification opportunities

- HS 300490: 18 buyer markets, $102.3B calculated opportunity.
- HS 300215: 9 buyer markets, $51.9B calculated opportunity.
- HS 382499: 9 buyer markets, $16.8B calculated opportunity.
- HS 300212: 8 buyer markets, $16.5B calculated opportunity.
- HS 300220: 5 buyer markets, $19.2B calculated opportunity.
- HS 300439: 5 buyer markets, $10.7B calculated opportunity.
- HS 330499: 5 buyer markets, $8.8B calculated opportunity.
- HS 382200: 5 buyer markets, $8.1B calculated opportunity.
- HS 330210: 3 buyer markets, $10.7B calculated opportunity.
- HS 293499: 3 buyer markets, $8.3B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.